58 results
S-3ASR
EX-4.3
MRNA
Moderna Inc
5 May 23
Automatic shelf registration
7:31am
herein relating thereto;
(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions … or investigation as is necessary to enable him to express an informed opinion as to whether or not such condition or covenant has been complied with; and
(4
S-3ASR
EX-4.4
MRNA
Moderna Inc
5 May 23
Automatic shelf registration
7:31am
as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;
(3 … ) a statement that, in the opinion of each such individual, he has made such examination or investigation as is necessary to enable him to express
8-K/A
EX-10.1
gpr6brv2amqe
1 Jun 22
Departure of Directors or Certain Officers
4:31pm
8-K/A
EX-10.1
2e0h5ml 5nq
13 May 22
Departure of Directors or Certain Officers
4:05pm
8-K/A
4ocgl9p6s sc
13 May 22
Departure of Directors or Certain Officers
4:05pm
8-K
p9c myd6uku14
11 May 22
Departure of Directors or Certain Officers
8:01am
8-K
EX-99.1
ur0cl3v7cbbue53m
4 May 22
Moderna Reports First Quarter 2022 Financial Results and Provides Business Updates
6:58am
8-K
EX-99.1
2zxn5xjh
24 Feb 22
Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
7:16am
8-K
EX-1.1
hkvhcmokrsa9
20 May 20
Moderna Announces Pricing of Public Offering of Shares of Common Stock
5:15pm
424B5
0qo8wc11p3 65qe
20 May 20
Prospectus supplement for primary offering
5:11pm